Investigating Drug-induced Mitochondrial Toxicity: A Biosensor to Increase Drug Safety?
Journal:
Current Drug Safety
Volume:
4
Page:
34-54
Author(s):
Claudia V. Pereira, Ana C. Moreira, Susana P. Pereira, Nuno G. Machado, Filipa S. Carvalho, Vilma A. Sardao and Paulo J. Oliveira
Niacin Status, NAD Distribution and ADP-Ribose Metabolism
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
3-11
Author(s):
James B. Kirkland
Nicotinamide Phosphoribosyltransferase (Nampt): A Link Between NAD Biology, Metabolism, and Diseases
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
20-28
Author(s):
Shin-ichiro Imai
The Evolving Roles of Nuclear Cardiology
Journal:
Current Cardiology Reviews
Volume:
5
Page:
52-55
Author(s):
Andrea De Lorenzo
The Potential of p38 MAPK Inhibitors to Modulate Periodontal Infections
Journal:
Current Drug Metabolism
Volume:
10
Page:
55-67
Author(s):
Keith L. Kirkwood, Carlos Rossa and Jr.
Inflammatory Cardiovascular Risk Markers in Obstructive Sleep Apnoea Syndrome
Journal:
Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume:
7
Page:
76-81
Author(s):
Silke Ryan and Walter T. McNicholas
Advances in Peptide Pharmaceuticals
Journal:
Current Pharmaceutical Biotechnology
Volume:
10
Page:
122-137
Author(s):
Cynthia L. Stevenson
Role of ARBs in the Blood Hypertension Therapy and Prevention of Cardiovascular Events
Journal:
Current Drug Targets
Volume:
10
Page:
20-25
Author(s):
S. Novo, M. Lunetta, S. Evola and G. Novo
Emerging Drug Candidates of Dipeptidyl Peptidase IV (DPP IV) Inhibitor Class for the Treatment of Type 2 Diabetes
Journal:
Current Drug Targets
Volume:
10
Page:
71-87
Author(s):
Rajesh Gupta, Sameer S. Walunj, Ranjeet K. Tokala, Kishore V.L. Parsa, Santosh Kumar Singh and Manojit Pal
Is there any Additional Prognostic Value of Central Blood Pressure Wave Forms Beyond Peripheral Blood Pressure?
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
254-266
Author(s):
Miso Sabovic, Michel E. Safar and Jacques Blacher